cfDNA showed a trend towards reduction in relapse-free patients, but showed a 2-20-fold increases in relapsed patients.
2
—
—
The sentences
Of the 49 proteins, increased NY-ESO-1 was present in 50% of the patients and was a highly significant inferior survival prognostic biomarker.